Planet Labs Navigating Extended Defense Sales Cycles: Analyst Cuts Price Target By 23%

Benchmark analyst Josh Sullivan reiterated a Buy rating on the shares of Planet Labs PBC PL and lowered the price target from $6.5 to $5.

PL reported 2QFY24 revenues of $53.8 million versus the Street’s $54.1 million.

FY24 revenue guidance was reduced below the Street’s

 view, due to defense sales cycles extending.

For the year, net dollar retention rate (NDR) was lowered to 115% due to the delay of an eight figure ACV expansion opportunity with a large government customer, noted the analyst.

Also ReadThese Analysts Cut Their Forecasts On Planet Labs After Weak Q2 Results

With the recent restructuring, PL will enter FY25 with a $35 million reduction in annual operating expenses run-rate versus the start of FY24.

The analyst noted that PL has also realigned resources focusing on its highest priority growth areas defense & intelligence, civil government and agriculture solutions.

The analyst believes that as macros and extending sales cycles lean on the industry at large, PL is in a position to control costs while playing consolidator of attractive but financially stressed assets.

The reduction in price target reflects the softening outlook near-term, said the analyst.

Piece Action: PL shares are trading lower by 13.3% at $2.67 on the last check Friday.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorEquitiesNewsPenny StocksPrice TargetReiterationSmall CapMarketsAnalyst RatingsTrading IdeasGeneralBriefsExpert Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!